Major Professor: Rice
Email: n.heydarian@ou.edu
Hometown:
Saqqez, Kurdistan, Iran
Education:
B.S., Animal Biology, Maitreyi College, University of Urmia
M.S., Cellular and Molecular Biology, Azad University
M.S., Biochemistry, University of Oklahoma
I am dedicated to improving human health and alleviating diseases. I believe Biochemistry allows me to the development of new anti-infectious drugs and inhibitors, while at the same time enables me to decipher the mechanism of infectious diseases.
I am a fourth-year PhD candidate working with Dr. Charles V. Rice. My research focuses on developing a technology that improves chronic wound healing. I am investigating polymer potentiators called BPEI (Branched Polyethylenimine) and its less-cytotoxic derivative PEG-BPEI against factors that impair wound healing process including antibiotic resistance, biofilm formation, and over-production of inflammation response. I have worked on a group of multi-drug resistant bacteria called carbapenem-resistant Enterobacteriaceae (CRE) and I have shown that the potentiator molecules can re-potentiate drug-resistant CRE bacteria against the existing antibiotics in the market. Furthermore, I have used the potentiator molecules to eliminate assemblages of surface-associated microbial cells, called biofilms, that attach to wound surfaces and are very hard to kill with standard of care antibiotics. I have demonstrated that applying BPEI and PEG-BPEI as dressings on the surface of CRE biofilms can eradicate the bacterial communities and restrict their survival. I am currently working on the immunology of chronic wounds and reducing the excess inflammation that develops in these wounds. I have shown that the potentiators can reduce the excess immune response caused by bacterial debris in human immune cells. The inflammation reduction can help to prevent many acute ulcers from becoming chronic wounds, therefore alleviating the risk of recurrent infection and impaired wound repair.
After receiving my PhD, I would like to join the pharmaceutical and biotech industry to help build pipelines of anti-infective drugs.
Publications, Presentations & Awards
Published
Submitted Transcripts